TI
EGRX

Trexquant Investment’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Trexquant Investment’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-43,723
Closed -$163K – 1924
2024
Q3 		$163K Sell
43,723
-9,230
-17% -$44K ﹤0.01% 1455
2024
Q2 		$297K Sell
52,953
-36,489
-41% -$159K ﹤0.01% 1367
2024
Q1 		$469K Sell
89,442
-36,840
-29% -$202K 0.01% 1168
2023
Q4 		$660K Buy
126,282
+59,095
+88% +$583K 0.01% 972
2023
Q3 		$1.06M Buy
67,187
+13,910
+26% +$250K 0.03% 731
2023
Q2 		$1.04M Buy
53,277
+38,119
+251% +$904K 0.03% 744
2023
Q1 		$430K Buy
+15,158
New +$450K 0.01% 1059
2021
Q2 		– Sell
-11,027
Closed -$460K – 1581
2021
Q1 		$460K Buy
+11,027
New +$512K 0.04% 548
2020
Q4 		– Sell
-18,954
Closed -$805K – 1586
2020
Q3 		$805K Buy
+18,954
New +$829K 0.05% 495
2020
Q2 		– Sell
-19,739
Closed -$908K – 1554
2020
Q1 		$908K Buy
+19,739
New +$991K 0.07% 448
2019
Q2 		– Sell
-8,753
Closed -$442K – 1191
2019
Q1 		$442K Sell
8,753
-12,652
-59% -$563K 0.03% 613
2018
Q4 		$862K Buy
21,405
+17,897
+510% +$922K 0.05% 460
2018
Q3 		$243K Buy
+3,508
New +$266K 0.02% 759

Other funds holding EGRX

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
SLG
Stanley-Laman Group Berwyn, Pennsylvania $814M AUM 40.24% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
AIC
Archer Investment Corporation Carmel, Indiana $469M AUM 19.1% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Trexquant Investment's EGRX Position: Q4 2024 in Review

Trexquant Investment sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q4 2024, closing a stake of 43,723 shares — an estimated $163K sold.

Trexquant Investment first reported a position in EGRX in Q3 2018 and held it in 13 quarters. The position peaked at $1.06M in Q3 2023. 9 funds tracked by Wall St. Rank hold EGRX as of Q4 2024.

  • Trexquant Investment reported no remaining Eagle Pharmaceuticals, Inc. position as of Q4 2024 after selling out during the quarter.
  • Trexquant Investment sold 43,723 Eagle Pharmaceuticals, Inc. shares in Q4 2024, an estimated $163K.
  • Trexquant Investment first reported a position in Eagle Pharmaceuticals, Inc. in Q3 2018 and held it in 13 quarters.
  • Trexquant Investment's Eagle Pharmaceuticals, Inc. position peaked at $1.06M in Q3 2023.
  • 9 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q4 2024.

Based on Trexquant Investment's 13F filing for Q4 2024, filed 12 Feb 2025.